Severe treatment-refractory antibody positive autoimmune autonomic ganglionopathy after mRNA COVID19 vaccination

BACKGROUND: COVID-19 vaccine-associated peripheral and central neuroimmunological disorders have been well described. We present the case of a 56 year old male who developed α3-ganglionic AChR antibody positive Autoimmune Autonomic Ganglionopathy (AAG) after completion of a two-dose course of mRNA (...

Descripción completa

Detalles Bibliográficos
Autores principales: Rowe, Simon, Spies, Judith M., Urriola, Nicolás
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484853/
https://www.ncbi.nlm.nih.gov/pubmed/36210629
http://dx.doi.org/10.1016/j.autrev.2022.103201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484853/
https://www.ncbi.nlm.nih.gov/pubmed/36210629
http://dx.doi.org/10.1016/j.autrev.2022.103201

Ejemplares similares